
Ultragenyx Pharmaceutical Inc.
USD22.41
+0.63 (+2.89%)
CEO
Emil D. Kakkis
IPO Date
2014-01-31
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$21.85
Prev. Close
$21.78
Day Low
$21.80
Day High
$22.59
52W Low
$18.29
52W High
$42.37
Market Cap
$2.21B
Volume
1.77M
| 26 Sept 2024 |
| RBC Capital |
| Outperform |
| Outperform |
| maintain |
| 20 Sept 2024 | Cantor Fitzgerald | Overweight | Overweight | maintain |
| 16 Sept 2024 | Cantor Fitzgerald | Overweight | Overweight | maintain |
| 5 Aug 2024 | Barclays | Overweight | Overweight | maintain |
| 2 Aug 2024 | Wells Fargo | Overweight | Overweight | maintain |
| 2 Aug 2024 | Wedbush | Neutral | Neutral | maintain |
| 2 Aug 2024 | Goldman Sachs | Buy | Buy | maintain |